140 related articles for article (PubMed ID: 27663951)
1. Radiotherapy induced dermatitis is a strong predictor for late fibrosis in head and neck cancer. The development of a predictive model for late fibrosis.
Nevens D; Duprez F; Daisne JF; Laenen A; De Neve W; Nuyts S
Radiother Oncol; 2017 Feb; 122(2):212-216. PubMed ID: 27663951
[TBL] [Abstract][Full Text] [Related]
2. Upfront vs. no upfront neck dissection in primary head and neck cancer radio(chemo)therapy: Tumor control and late toxicity.
Nevens D; Duprez F; Bonte K; Deron P; Huvenne W; Laenen A; De Neve W; Nuyts S
Radiother Oncol; 2017 Aug; 124(2):220-224. PubMed ID: 28756006
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy related skin toxicity (RAREST-01): Mepitel® film versus standard care in patients with locally advanced head-and-neck cancer.
Narvaez C; Doemer C; Idel C; Setter C; Olbrich D; Ujmajuridze Z; Carl JH; Rades D
BMC Cancer; 2018 Feb; 18(1):197. PubMed ID: 29454311
[TBL] [Abstract][Full Text] [Related]
4. Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck.
Andrä C; Rauch J; Li M; Ganswindt U; Belka C; Saleh-Ebrahimi L; Ballhausen H; Nachbichler SB; Roeder F
Radiat Oncol; 2015 Jul; 10():140. PubMed ID: 26156022
[TBL] [Abstract][Full Text] [Related]
5. Topical use of Jiawei Simiao Yongan Gao to prevent radiodermatitis in patients with head and neck cancer: A retrospective cohort study.
Song F; Liao Z; Li T; Kang N; Li Z; Fan S; Liu F
Medicine (Baltimore); 2020 Nov; 99(48):e23318. PubMed ID: 33235092
[TBL] [Abstract][Full Text] [Related]
6. Hypericum perforatum and neem oil for the management of acute skin toxicity in head and neck cancer patients undergoing radiation or chemo-radiation: a single-arm prospective observational study.
Franco P; Potenza I; Moretto F; Segantin M; Grosso M; Lombardo A; Taricco D; Vallario P; Filippi AR; Rampino M; Ricardi U
Radiat Oncol; 2014 Dec; 9():297. PubMed ID: 25544371
[TBL] [Abstract][Full Text] [Related]
7. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
[TBL] [Abstract][Full Text] [Related]
8. DeCoP, a Dermatitis Control Program using a moderately absorbent surgical pad for head and neck cancer patients receiving radiotherapy: a retrospective analysis.
Zenda S; Ishi S; Akimoto T; Arahira S; Motegi A; Tahara M; Hayashi R; Asanuma C
Jpn J Clin Oncol; 2015 May; 45(5):433-8. PubMed ID: 25673153
[TBL] [Abstract][Full Text] [Related]
9. Preemptive treatment with Xonrid®, a medical device to reduce radiation induced dermatitis in head and neck cancer patients receiving curative treatment: a pilot study.
Iacovelli NA; Naimo S; Bonfantini F; Cavallo A; Bossi P; Fallai C; Pignoli E; Alfieri S; Bergamini C; Favales F; Orlandi E
Support Care Cancer; 2017 Jun; 25(6):1787-1795. PubMed ID: 28108819
[TBL] [Abstract][Full Text] [Related]
10. Multicenter Randomized Double-Blind, Placebo-Controlled Trial GORTEC (Groupe Oncologie Radiotherapie Tete et Cou) 2009-01 Evaluating the Effect of the Regenerating Agent on Radiodermatitis of Head and Neck Cancer Patients.
Tao Y; Auperin A; Sire C; Martin M; Saliou MG; Bardet E; Sun XS; Chatellier T; Morand C; Cornely A; Angokai M; Di Rito A; Kichenin K; Blanchard P; D'Onofrio I; Bourhis J
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):590-595. PubMed ID: 29280453
[TBL] [Abstract][Full Text] [Related]
11. Management of acute skin toxicity with Hypericum perforatum and neem oil during platinum-based concurrent chemo-radiation in head and neck cancer patients.
Franco P; Rampino M; Ostellino O; Schena M; Pecorari G; Garzino Demo P; Fasolis M; Arcadipane F; Martini S; Cavallin C; Airoldi M; Ricardi U
Med Oncol; 2017 Feb; 34(2):30. PubMed ID: 28101834
[TBL] [Abstract][Full Text] [Related]
12. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
Salama JK; Stenson KM; List MA; Mell LK; Maccracken E; Cohen EE; Blair E; Vokes EE; Haraf DJ
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1060-5. PubMed ID: 18936351
[TBL] [Abstract][Full Text] [Related]
13. Preliminary results using twice-a-day fractionation in the radiotherapeutic management of advanced cancers of the head and neck.
Jampolis S; Pipard G; Horiot JC; Bolla M; Le Dorze C
AJR Am J Roentgenol; 1977 Dec; 129(6):1091-3. PubMed ID: 413365
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.
Rades D; Stoehr M; Meyners T; Bohlen G; Nadrowitz R; Dunst J; Schild SE; Wroblewski J; Albers D; Schmidt R; Alberti W; Tribius S
Strahlenther Onkol; 2008 Apr; 184(4):198-205. PubMed ID: 18398584
[TBL] [Abstract][Full Text] [Related]
15. Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck.
Mendenhall WM; Morris CG; Amdur RJ; Hinerman RW; Mancuso AA
Head Neck; 2003 Jul; 25(7):535-42. PubMed ID: 12808656
[TBL] [Abstract][Full Text] [Related]
16. Photobiomodulation therapy for the prevention of acute radiation dermatitis in head and neck cancer patients (DERMISHEAD trial).
Robijns J; Lodewijckx J; Claes S; Van Bever L; Pannekoeke L; Censabella S; Bussé L; Colson D; Kaminski I; Broux V; Puts S; Vanmechelen S; Timmermans A; Noé L; Bulens P; Govers M; Maes A; Mebis J
Radiother Oncol; 2021 May; 158():268-275. PubMed ID: 33711412
[TBL] [Abstract][Full Text] [Related]
17. Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.
Palazzi M; Tomatis S; Orlandi E; Guzzo M; Sangalli C; Potepan P; Fantini S; Bergamini C; Gavazzi C; Licitra L; Scaramellini G; Cantu' G; Olmi P
Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):330-7. PubMed ID: 17881148
[TBL] [Abstract][Full Text] [Related]
18. Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT.
Studer G; Brown M; Salgueiro EB; Schmückle H; Romancuk N; Winkler G; Lee SJ; Sträuli A; Kissling B; Dummer R; Glanzmann C
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):110-7. PubMed ID: 20732757
[TBL] [Abstract][Full Text] [Related]
19. Topical application of a sandal wood oil and turmeric based cream prevents radiodermatitis in head and neck cancer patients undergoing external beam radiotherapy: a pilot study.
Palatty PL; Azmidah A; Rao S; Jayachander D; Thilakchand KR; Rai MP; Haniadka R; Simon P; Ravi R; Jimmy R; D'souza PF; Fayad R; Baliga MS
Br J Radiol; 2014 Jun; 87(1038):20130490. PubMed ID: 24694358
[TBL] [Abstract][Full Text] [Related]
20. Radiation-induced skin cancer and radiodermatitis of the head and neck.
van Vloten WA; Hermans J; van Daal WA
Cancer; 1987 Feb; 59(3):411-4. PubMed ID: 3791154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]